Terminology Service < Semantic Lookup Platform

All terms in GO

Label	Id	Description
hyaloid vascular plexus regression	GO_1990384	[The developmental process in which the hyaloid vascular plexus is destroyed as a part of its normal progression.]
anatomical structure regression	GO_0060033	[The developmental process in which an anatomical stucture is destroyed as a part of its normal progression.]
camera-type eye development	GO_0043010	[The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.]
ubiquitin-specific protease binding	GO_1990381	[Interacting selectively and non-covalently with a ubiquitin-specific protease.]
protease binding	GO_0002020	[Interacting selectively and non-covalently with any protease or peptidase.]
obsolete melanosome assembly	GO_1990382	[OBSOLETE. The aggregation, arrangement and bonding together of a set of components to form a melanosome, a tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored.]
Lys48-specific deubiquitinase activity	GO_1990380	[Hydrolysis of Lys48-linked ubiquitin unit(s) from a ubiquitinated protein.]
ubiquitinyl hydrolase activity	GO_0101005	[Catalysis of the hydrolysis of ubiquitin from proteins and other molecules.]
protein K48-linked deubiquitination	GO_0071108	[A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein.]
discoidal high-density lipoprotein particle	GO_0034365	[A newly formed high-density lipoprotein particle; consists of a phospholipid bilayer surrounded by two or more APOA1 molecules. The discoidal HDL particle is formed when lipid-free or lipid-poor APOA1 acquires phospholipids and unesterified cholesterol from either cell membranes or triglyceride-rich lipoproteins (undergoing lipolysis by lipoprotein lipase).]
high-density lipoprotein particle	GO_0034364	[A lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE; found in blood and carries lipids from body tissues to the liver as part of the reverse cholesterol transport process.]
spherical high-density lipoprotein particle	GO_0034366	[A mature high-density lipoprotein (HDL) particle, converted from discoidal HDL particles following the esterification of cholesterol in the particle by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).]
intermediate-density lipoprotein particle	GO_0034363	[A triglyceride-rich lipoprotein particle that typically contains APOB100, APOE and APOCs and has a density of 1.006-1.019 g/ml and a diameter of between 25-30 nm. IDL particles are found in blood and are formed by the delipidation of very-low-density lipoprotein particles (VLDL). IDL particles are removed from blood by the liver, following binding to the APOE receptor, or are converted to low-density lipoprotein (LDL).]
triglyceride-rich plasma lipoprotein particle	GO_0034385	[A plasma lipoprotein particle that has a hydrophobic core enriched in triglycerides surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Triglyceride-rich lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood.]
protein-lipid complex remodeling	GO_0034368	[The acquisition, loss or modification of a protein or lipid within a protein-lipid complex.]
protein-containing complex remodeling	GO_0034367	[The acquisition, loss, or modification of macromolecules within a complex, resulting in the alteration of an existing complex.]
protein-containing complex subunit organization	GO_0043933	[Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein complex.]
protein-lipid complex subunit organization	GO_0071825	[Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein-lipid complex.]
very-low-density lipoprotein particle	GO_0034361	[A triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm. It is found in blood and transports endogenous products (newly synthesized cholesterol and triglycerides) from the liver.]
low-density lipoprotein particle	GO_0034362	[A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver.]